Skip to main content
S 272 119th Congress Senate Health Child health Congressional oversight Consumer affairs Food supply, safety, and labeling Government information and archives Manufacturing Nutrition and diet Supply chain

Protect Infant Formula from Contamination Act

Introduced: January 28, 2025 Introduced by: Peters, Gary C. Democratic · Michigan See on congress.gov
 Everywhere this bill has been 10 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 4, 2026
Held at the desk.
May 4, 2026
Received in the House.
May 1, 2026
Message on Senate action sent to the House.
Apr 28, 2026
Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (consideration: CR S2074-2075; text: CR S2074)
Apr 28, 2026
Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.
Jan 28, 2026
Placed on Senate Legislative Calendar under General Orders. Calendar No. 306.
Jan 28, 2026
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report.
Jan 15, 2026
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Jan 28, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 28, 2025
Introduced in Senate
 Plain-English summary Congressional Research Service

Protect Infant Formula from Contamination Act

This bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula. 

Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded. 

Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day. 

Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action. 

Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues.  

What's happening now May 4, 2026

Held at the desk.

 Committees of jurisdiction 1